EKTAF.US Elekta AB (publ)

Healthcare Health Care Equipment & Supplies USA Stocks
6.36 USD
Close of Nov 13, 2026
4.39 6.69
Market cap
USD 2.33B
P/E
-
P/B
3.05x
ROE
14.0%
Dividend yield
3.94%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is EKTAF.US undervalued?

Graham number

The Graham number of Elekta AB (publ) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Elekta AB (publ) fundamental analysis

No fundamental analysis for Elekta AB (publ) yet.

Elekta AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-compl…

Full company profile